''Immunovia AB...today announced the launch of ASSURE, a post-marketing registry evaluating the real-world clinical impact of its commercially available blood-based biomarker test, PancreaSure. The study is designed to capture clinical data on how PancreaSure influences clinician decision-making in pancreatic cancer surveillance. Data generated in ASSURE will support Immunovia's reimbursement efforts and clinician adoption of the test.''